Navneet Dogra, PhD Email Navneet Dogra
- ASSISTANT PROFESSOR | Genetics and Genomic Sciences
- ASSISTANT PROFESSOR | Pathology, Molecular and Cell Based Medicine
Dr. Dogra is an Assistant Professor at the Department of Genetics and Genomic Sciences, and Department of Pathology, Molecular and Cell-Based Medicine. His laboratory is working on the emerging field of liquid biopsy in cancer, including: 1) Exosomes and Extracellular vesicles – nanoparticles actively secreted by tumor and benign tissue in human biofluids, 2) Cell-free DNA, RNA, and proteins – non-invasive tools for monitoring real time disease state, through RNA Sequencing, qRT-PCR, Proteomics etc., and 3) Bioengineering – intersection of nanotechnology, microfluidics, drug delivery, and bioinformatics.
Prior to Mount Sinai, he led research efforts at IBM research and Yale University to drive translational research in “liquid biopsy in cancer” and “drug delivery” by bridging together clinical and experimental oncology and develop novel tools for biosensing of genetic markers.
Dr. Dogra has recently filed for two US patents relating to “exosomes nanoparticles assisted drug delivery” and “tumor heterogeneity”. He has published in a diverse array of journals including Cell (research featured on the cover), Lab-on-a-chip), ACS Applied Materials and Interfaces (cover feature), ACS Bioconjugate Chemistry, Langmuir (cover feature), and Scientific Reports.
Dr. Dogra’s research has been featured in multiple media outlets including Yale News, NBC News, Yale Engineering Magazine, Science Daily, Futurity, R&D Magazine, Fox News, and Wall Street Journal
IBM “5 in 5” groundbreaking research award, Watson Research Center, NY
IBM Outstanding Technical Achievement Award, Watson Research Center, NY
Yale University Young Global Scholars Program, Falling Walls Finalist, New Haven, CT
Oak Ridge National Lab, TN, Summer Fellowship
Gower Research Fellow (Outstanding graduate student award), SIU, Carbondale IL
Dissertation research award, Southern Illinois University Carbondale, IL
Full list of publications :
Anti-Tumor Therapy, Biochemistry, Biomedical Informatics, Biomedical Sciences, Blood, Blood-Brain Barrier, Brain, Cancer, Cancer Genetics, Cell Biology, Clinical Genomics, Gene Discovery, Gene Expressions, Gene Therapy, Genetics, Genomics, Imaging, Intracellular Transport, Mass Spectrometry, Membranes, Microarray, Nanotechnology, Oncogenes, Parkinson's Disease, Pathology, Prostate, Protein Trafficking & Sorting, RNA, RNA Transport & Localization, Signal Transduction, Spectroscopy, Tissue Engineering, Trafficking, Tumor Suppressor Genes, Tumorigenesis, Two-Photon Imaging, Viruses and Virology
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Genetics and Data Science [GDS], Pharmacology and Therapeutics Discovery [PTD]
Bachelor's of Science, Himachal Pradesh University
Doctorate, Southern Illinois University Carbondale
Master's of Science, Guru Nanak Dev University
Post Doctorate, IBM Watson Research Center
Post Doctorate, Yale University
Outstanding Technical Achievement Award
IBM Watson Research Center
“5 in 5” groundbreaking research award
IBM Watson Research Center
Five ground-breaking scientific innovations with the potential to change the way people live, work and interact over the next five years.
Yale Young Global Scholars Program, Falling Walls Finalist
interdisciplinary research for young academics
Dissertation research award
Gower Research Fellow
Liquid-Biopsy in Cancer
Can we detect cancer biomarkers present in bodily fluids and avoid unnecessary surgical procedures? To answer this question, my research is focused on developing new liquid biopsy methods using circulating exosomes and extracellular vesicles, microfluidics, and next-gen genomic technologies.
Exosomes and nanoparticles for drug delivery
Exosomes and other Extracellular Vesicles
Used for diagnostics, therapy, and bioengineering
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Dogra did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.